Bank OZK Takes $1.70 Million Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Bank OZK bought a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 21,744 shares of the company’s stock, valued at approximately $1,700,000.

Several other large investors also recently modified their holdings of GEHC. LGT Financial Advisors LLC grew its holdings in shares of GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after buying an additional 251 shares in the last quarter. Capital Performance Advisors LLP acquired a new position in GE HealthCare Technologies during the third quarter valued at approximately $26,000. Ashton Thomas Securities LLC acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at approximately $26,000. Darwin Wealth Management LLC acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at approximately $31,000. Finally, Continuum Advisory LLC lifted its holdings in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after purchasing an additional 168 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

GEHC has been the subject of several research reports. Citigroup lifted their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $97.67.

GE HealthCare Technologies Stock Down 2.3 %

Shares of GEHC opened at $87.35 on Friday. The company has a market capitalization of $39.94 billion, a PE ratio of 20.17, a PEG ratio of 3.19 and a beta of 1.15. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80. The stock’s 50-day moving average price is $86.17 and its two-hundred day moving average price is $86.10. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.